Anavex Life Sciences Corp (AVXL) reports a robust financial runway and unveils encouraging results for blarcamesine, despite ...

Rates of diagnosis and treatment are low, so there is a need for diagnostic tests and biomarkers for classification and ...

Anavex faces dilution risk from its $150M ATM facility, high cash burn, and lack of revenue. Click here to see why AVXL stock ...